GLP-1 class compounds. Semaglutide, tirzepatide, and liraglutide are authorised medicinal products within the Netherlands and carry elevated regulatory and import scrutiny. Any framing that provides them as therapeutic alternate options to prescription medicines provides them under the Geneesmiddelenwet and its promotion procedures, which the IGJ a